Establishment of a Bayesian network model to predict the survival of malignant peritoneal mesothelioma patients after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy

Reference

• Sun LB, Li CG, Gao SH. Diffuse malignant peritoneal mesothelioma: a review. Front Surg. 2022;9:1015884.
   PubMed Web of Science ®Google Scholar
• Boffetta P. Epidemiology of peritoneal mesothelioma: a review. Ann Oncol. 2007;18(6):985–990.
   PubMed Web of Science ®Google Scholar
• Zhao J, Zuo TT, Zheng RS, et al. Epidemiology and trend analysis on malignant mesothelioma in China. Chin J Cancer Res. 2017;29(4):361–368.
   PubMed Web of Science ®Google Scholar
• Zhai YR, Hui ZG, Chen WQ, et al. The epidemic of malignant mesothelioma in China: a prediction of incidence during 2016-2030. Transl Lung Cancer Res. 2022;11(12):2403–2411.
   PubMed Web of Science ®Google Scholar
• Yang R, Su YD, Ma R, et al. Clinical epidemiology of peritoneal metastases in China: the construction of professional peritoneal metastases treatment centers based on the prevalence rate. Eur J Surg Oncol. 2023;49(1):173–178.
   PubMed Web of Science ®Google Scholar
• Helm JH, Miura JT, Glenn JA, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: a systematic review and meta-analysis. Ann Surg Oncol. 2015;22(5):1686–1693.
   PubMed Web of Science ®Google Scholar
• Yu J, Smith VA, Wang PP, et al. Advances to Bayesian network inference for generating causal networks from observational biological data. Bioinformatics. 2004;20(18):3594–3603.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Wang W, Liang H, et al. The optimal treatment for stage IIIA-N2 non-small cell lung cancer: a network meta-analysis. Ann Thorac Surg. 2019;107(6):1866–1875.
   PubMed Web of Science ®Google Scholar
• Trilla-Fuertes L, Gamez-Pozo A, Arevalillo JM, et al. Bayesian networks established functional differences between breast cancer subtypes. PLOS One. 2020;15(6):e0234752.
   PubMed Web of Science ®Google Scholar
• Wu YH, Li Q, Cai ZQ, et al. Survival prediction for gallbladder carcinoma after curative resection: comparison of nomogram and Bayesian network models. Eur J Surg Oncol. 2020;46(11):2106–2113.
   PubMed Web of Science ®Google Scholar
• Liu GC, Yang Z, Wang DB. A Bayesian network predicting survival of cervical cancer patients-based on surveillance, epidemiology, and end results. Cancer Sci. 2023;114(3):1131–1141.
   PubMed Web of Science ®Google Scholar
• Stojadinovic A, Bilchik A, Smith D, et al. Clinical decision support and individualized prediction of survival in colon cancer: Bayesian belief network model. Ann Surg Oncol. 2013;20(1):161–174.
   PubMed Web of Science ®Google Scholar
• Zhao X, Li XB, Lin YL, et al. Survival prediction by Bayesian network modeling for Pseudomyxoma peritonei after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy. Cancer Med. 2023;12(3):2637–2645.
   PubMed Web of Science ®Google Scholar
• Su YD, Yang ZR, Li XB, et al. Key factors for successful cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat diffuse malignant peritoneal mesothelioma: results from specialized peritoneal cancer center in China. Int J Hyperthermia. 2022;39(1):706–712.
   PubMed Web of Science ®Google Scholar
• Peritoneal Cancer Professional Committee of CACA, Cancer Hyperthermia Professional Committee of CACA, Cancer Hyperthermia Professional Committee of Beijing Cancer Prevention & Treatment Society. Chinese expert consensus on diagnosis and treatment of diffuse malignant peritoneal mesothelioma. Natl Med J China. 2021;101(36):2839–2849.
   Google Scholar
• Sugarbaker PH. Cytoreduction surgery and perioperative intraperitoneal chemotherapy as a curative approach to Pseudomyxoma peritonei syndrome. Eur J Surg Oncol. 2001;27(3):239–243.
   PubMed Web of Science ®Google Scholar
• Miller J, Wynn WH. Malignant tumor arising from the endothelium of the peritoneum, and producing a mucoid ascitic fluid. J. Pathol. 1908;12(2):267–278.
   Google Scholar
• Li CY, Alexander HR. Jr. Peritoneal metastases from malignant mesothelioma. Surg Oncol Clin N Am. 2018;27(3):539–549.
   PubMed Web of Science ®Google Scholar
• Wang S, Ma K, Chen ZW, et al. A nomogram to predict prognosis in malignant pleural mesothelioma. World J Surg. 2018;42(7):2134–2142.
   PubMed Web of Science ®Google Scholar
• Chen SH, Yu WH, Shao SH, et al. Establishment of predictive nomogram and web-based survival risk calculator for malignant pleural mesothelioma: a SEER database analysis. Front Oncol. 2022;12:1027149.
   PubMed Web of Science ®Google Scholar
• Zhuo ML, Zheng QW, Chi YJ, et al. Survival analysis via nomogram of surgical patients with malignant pleural mesothelioma in the surveillance, epidemiology, and end results database. Thorac Cancer. 2019;10(5):1193–1202.
   PubMed Web of Science ®Google Scholar
• Schaub NP, Alimchandani M, Quezado M, et al. A novel nomogram for peritoneal mesothelioma predicts survival. Ann Surg Oncol. 2013;20(2):555–561.
   PubMed Web of Science ®Google Scholar
• Li R, Zhang C, Du K, et al. Analysis of prognostic factors of rectal cancer and construction of a prognostic prediction model based on Bayesian network. Front Public Health. 2022;10:842970.
   PubMed Web of Science ®Google Scholar
• Stojadinovic A, Nissan A, Eberhardt J, et al. Development of a Bayesian belief network model for personalized prognostic risk assessment in colon carcinomatosis. Am Surg. 2011;77(2):221–230.
   PubMed Web of Science ®Google Scholar
• Li Q, Zhang J, Cai Z, et al. A Bayesian network prediction model for microvascular invasion in patients with intrahepatic cholangiocarcinoma: a multi-institutional study. World J Surg. 2023;47(3):773–784.
   PubMed Web of Science ®Google Scholar
• Nizri E, Kusamura S, Fallabrino G, et al. Dose-dependent effect of red blood cells transfusion on perioperative and long-term outcomes in peritoneal surface malignancies treated with cytoreduction and HIPEC. Ann Surg Oncol. 2018;25(11):3264–3270.
   PubMed Web of Science ®Google Scholar
• Acs M, Gerken M, Gajic I, et al. Ten-year single-center experience with treatment of primary diffuse malignant peritoneal mesothelioma (DMPM) by cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Langenbecks Arch Surg. 2022;407(7):3057–3067.
   PubMed Web of Science ®Google Scholar
• Leinwand JC, Taub RN, Chabot JA, et al. Two-stage cytoreductive surgery and intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma: predictors of overall survival in an intention-to-treat series. Ann Surg Oncol. 2020;27(7):2539–2547.
   PubMed Web of Science ®Google Scholar
• Shamavonian R, Cheng E, Karpes JB, et al. Cytoreductive surgery and HIPEC for malignant peritoneal mesothelioma: outcomes and survival from an Australian Centre. Anticancer Res. 2022;42(6):2939–2944.
   PubMed Web of Science ®Google Scholar
• Kusamura S, Torres Mesa PA, Cabras A, et al. The role of Ki-67 and pre-cytoreduction parameters in selecting diffuse malignant peritoneal mesothelioma (DMPM) patients for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol. 2016;23(5):1468–1473.
   PubMed Web of Science ®Google Scholar
• Pillai K, Pourgholami MH, Chua TC, et al. Prognostic significance of Ki67 expression in malignant peritoneal mesothelioma. Am J Clin Oncol. 2015;38(4):388–394.
   PubMed Web of Science ®Google Scholar
• Yan TD, Deraco M, Baratti D, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol. 2009;27(36):6237–6242.
   PubMed Web of Science ®Google Scholar
• Yan TD, Yoo D, Sugarbaker PH. Significance of lymph node metastasis in patients with diffuse malignant peritoneal mesothelioma. Eur J Surg Oncol. 2006;32(9):948–953.
   PubMed Web of Science ®Google Scholar
• Xia A, Ma RQ, Zhai XC, et al. Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for Pseudomyxoma peritonei: a single-center experience with 854 patients. CJCO. 2020;47(3):145–151.
   Google Scholar
• Li XB, Yu Y, An SL, et al. Impacts of prior surgical score on the efficacy and safety of cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for Pseudomyxoma peritonei. Chin J Gen Surg. 2020;35(10):782–787.
   Google Scholar